| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at EWTX with holdings across 36 companies. Recent SEC Form 4 filings include 6 buys and 27 sells.
Estimated insider holdings value: $2043.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2021 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Sell | 1,109,644 | $6.09 | $6,757,731.96 | -13.8% | -57.4% | -87.2% | |
| Sep 7, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 8,084 | $33.99 | $274,793.91 | -0.1% | -35.3% | -59.8% | |
| Sep 2, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 37,864 | $34.08 | $1,290,550.08 | -0.4% | -41.3% | -63.7% | |
| Aug 30, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 18,073 | $34.07 | $615,747.82 | -0.2% | -27.6% | -65.5% | |
| Aug 25, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 18,215 | $34.17 | $622,426.25 | -0.2% | -27.3% | -63.9% | |
| Aug 18, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 20,328 | $34.10 | $693,210.46 | -0.3% | -16.7% | -63.5% | |
| Jul 16, 2021 | ELVN Enliven Therapeutics, Inc. | Director, 10% Owner | Buy | 1,666,666 | $6.00 | $9,999,996.00 | New | -31.7% | -79.3% | |
| Jun 15, 2021 | JANX Janux Therapeutics, Inc. | Director | Buy | 705,853 | $17.00 | $11,999,501.00 | +30.2% | +52.6% | -37.6% | |
| Apr 21, 2021 | NPCE Neuropace Inc | 10% Owner | Buy | 235,000 | $17.00 | $3,995,000.00 | New | -5.8% | -66.5% | |
| Mar 30, 2021 | IMA Imagenebio, Inc. | Director | Buy | 423,400 | $16.00 | $6,774,400.00 | +22.5% | -44.1% | -76.1% |